Home » Newsletters » BioWorld Science

BioWorld Science

June 23, 1997

View Archived Issues

Merck Frosst prepares prodrugs of COX-2 inhibitors

Anti-HBV nucleosides from Chong Kun Dang

Hypocholesterolemic compounds reported by Schering-Plough

Monoamine reuptake inhibitors disclosed by NeuroSearch

Matrix initiates phase II trial of IntraDose in primary liver cancer

Orally active MDP derivative as lead for antiallergic compounds

New orally active oligopeptide antiallergic from Central Drug Res. Inst.

IND filed for new anxiolytic compound, NGD-91-2

S.c. lepirudin vs. i.v. heparin for deep vein thrombosis

Novopharm Biotech and Genesys Pharma merger imminent

Gabitril introduced in Germany

Medac launches Oncaspar in Germany

Taxotere now available in Japan for non-small cell lung and breast cancers

Phase I studies reported for P&U fusion protein for GI malignancies

Melatonin reduces the effects of nifedipine in hypertensive patients

Preclinical studies on UR-7280, a potential antihypertensive agent

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026